Related Experiment Video
Updated: Jul 7, 2026
12:24
A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
Published on: September 30, 2021
5.1K
[Risk prediction model of hepatitis B associated hepatocellular carcinoma]
1Department of Infection, The Third Hospital of Hebei Medical University, Shijiazhuang 050051, China.
Summary
Hepatocellular carcinoma (HCC) is a major global cancer, often diagnosed late. This review covers risk factors and prediction models for HBV-associated HCC to improve early detection and management.
Area of Science:
- Hepatology
- Oncology
- Epidemiology
Background:
- Hepatocellular carcinoma (HCC) is a prevalent malignancy globally, posing significant health risks.
- Hepatocellular carcinoma diagnosis frequently occurs at advanced stages, leading to poor prognoses.
- Hepatitis B virus (HBV) infection is a primary driver of hepatocellular carcinoma.
Purpose of the Study:
- To review risk factors associated with HBV-related hepatocellular carcinoma.
- To summarize existing risk prediction models for HBV-associated HCC.
- To provide insights for monitoring and managing HBV-associated liver cancer risk.
Main Methods:
- Literature review of risk factors for hepatocellular carcinoma.
- Analysis of established risk prediction models for HBV-associated HCC.
- Synthesis of current knowledge on HBV-related liver cancer.
Main Results:
- HBV infection is a significant risk factor for hepatocellular carcinoma development.
- Various risk prediction models have been developed to aid early diagnosis.
- Early detection and intervention are crucial for improving patient outcomes.
Conclusions:
- Effective risk monitoring and management strategies are essential for HBV-associated HCC.
- Risk prediction models can enhance early diagnosis rates and reduce mortality.
- Further research into risk stratification can improve clinical outcomes for hepatocellular carcinoma patients.
